Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration

被引:159
作者
Petersén, Å
Larsen, KE
Behr, GG
Romero, N
Przedborski, S
Brundin, P
Sulzer, D
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ, Dept Psychiat, New York, NY 10032 USA
[4] New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA
[5] Lund Univ, Wallenberg Neurosci Ctr, Sect Neuronal Survival, S-22184 Lund, Sweden
关键词
D O I
10.1093/hmg/10.12.1243
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is caused by an expanded CAG repeat in exon 1 of the gene coding for the huntingtin protein. The cellular pathway by which this mutation induces HD remains unknown, although alterations in protein degradation are involved, To study intrinsic cellular mechanisms involved, To study Intrinsic to the mutation, we examined dissociated postnatally derived cultures of striatal neurons from transgenic mice expressing exon 1 of the human HD gene carrying a CAG repeat expansion. While there was no difference in cell death between wild-type and mutant littermate-derived cultures, the mutant striatal neurons exhibited elevated cell death following a single exposure to a neurotoxic concentration of dopamine, The mutant neurons exposed to dopamine also exhibited lysosome-associated responses including induction of autophagic granules and electron-dense lysosomes, The autophagic/lysosomal compartments co-localized with high levels of oxygen radicals in living neurons, and ubiquitin. The results suggest that the combination of mutant huntingtin and a source of oxyradical stress (provided in this case by dopamine) induces autophagy and may underlie the selective cell death characteristic of HD.
引用
收藏
页码:1243 / 1254
页数:12
相关论文
共 73 条
  • [51] Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
    Reddy, PH
    Williams, M
    Charles, V
    Garrett, L
    Pike-Buchanan, L
    Whetsell, WO
    Miller, G
    Tagle, DA
    [J]. NATURE GENETICS, 1998, 20 (02) : 198 - 202
  • [52] GLUTAMATE INDUCES THE PRODUCTION OF REACTIVE OXYGEN SPECIES IN CULTURED FOREBRAIN NEURONS FOLLOWING NMDA RECEPTOR ACTIVATION
    REYNOLDS, IJ
    HASTINGS, TG
    [J]. JOURNAL OF NEUROSCIENCE, 1995, 15 (05) : 3318 - 3327
  • [53] Evidence for free radical formation during the oxidation of 2′-7′-dichlorofluorescin to the fluorescent dye 2′-7′-dichlorofluorescein by horseradish peroxidase:: Possible implications for oxidative stress measurements
    Rota, C
    Chignell, CF
    Mason, RP
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 (7-8) : 873 - 881
  • [54] Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease
    Sapp, E
    Penney, J
    Young, A
    Aronin, N
    Vonsattel, JP
    DiFiglia, M
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (02) : 165 - 173
  • [55] Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
    Saudou, F
    Finkbeiner, S
    Devys, D
    Greenberg, ME
    [J]. CELL, 1998, 95 (01) : 55 - 66
  • [56] Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
    Schilling, G
    Becher, MW
    Sharp, AH
    Jinnah, HA
    Duan, K
    Kotzuk, JA
    Slunt, HH
    Ratovitski, T
    Cooper, JK
    Jenkins, NA
    Copeland, NG
    Price, DL
    Ross, CA
    Borchelt, DR
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (03) : 397 - 407
  • [57] WIDESPREAD EXPRESSION OF HUNTINGTONS-DISEASE GENE (IT15) PROTEIN PRODUCT
    SHARP, AH
    LOEV, SJ
    SCHILLING, G
    LI, SH
    LI, XJ
    BAO, J
    WAGSTER, MV
    KOTZUK, JA
    STEINER, JP
    LO, A
    HEDREEN, J
    SISODIA, S
    SNYDER, SH
    DAWSON, TM
    RYUGO, DK
    ROSS, CA
    [J]. NEURON, 1995, 14 (05) : 1065 - 1074
  • [58] Shinkai T, 1997, J NEUROSCI RES, V47, P393
  • [59] Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO
  • [60] 2-C